In addition, activation of the NAD-dependent deacetylase SIRT1 attenuates liver fibrosis through deacetylation of EZH2, which affects the stability of EZH2 and prevents myofibroblast generation [76]. The gene discussed is EZH2; the disease is Hepatic fibrosis.